John Busch Patient

John was diagnosed with multiple myeloma more than 16 years ago through a routine blood test revealing elevated proteins.  He is cycling as a “small token of my gratitude,” he said, for all that MMRF has done for myeloma patients, researchers and medical providers. Since 2006, he has endured numerous types of treatments, buoyed by incredible medical advancements, dedicated medical providers, family and friends, and spiritual inspiration, he adds. Busch is also riding “for all the folks who can’t participate,” he said. “It is a blessing to be able and fit enough to do something extraordinary like this ride.”

Sorry, there are no posts from this member.
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit

Learn More

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.

About Janssen Oncology